What is Canagliflozin?

Category: Prescription Drugs

Most popular types: Invokana

false

Canagliflozin is an oral antidiabetic medication that is designed to be used alongside diet and exercise to help improve glycemic control in adults with type 2 diabetes. This agent exerts its effect by regulating the amount of sugar that the body excretes in the urine.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 3
Moderate 6
Mild 2
None 13

Commonly reported side effects and conditions associated with Canagliflozin

Side effect Patients
Aggressive behavior 1
Candida (fungal) infection 1
Decreased kidney function 1
Diarrhea 1
Frequent urination 1
Mild depression 1

Show all 11 reported side effects

Dosages

Based on patients currently taking Canagliflozin

Dosage Patients
300 mg daily 7
100 mg daily 2
150 mg daily 2
1 mg daily 1

Why patients stopped taking Canagliflozin

Multiple reasons could be selected

Reason Patients
Side effects too severe 8
Doctor's advice 3
Other 2
Expense 1
See all 12 patients who've stopped taking Canagliflozin

Duration

Currently taking Canagliflozin

Duration Patients
1 - 2 years 1
2 - 5 years 12

Stopped taking Canagliflozin

Duration Patients
Less than 1 month 2
1 - 6 months 1
6 months - 1 year 2
1 - 2 years 5
2 - 5 years 2
Adherence
Adherence Evaluations
Always 21
Usually 2
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 2
Somewhat hard to take 1
A little hard to take 1
Not at all hard to take 20
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 1
$50-99 2
$25-49 4
< $25 9
Not specified 8

What people switch to and from

Patients started taking Canagliflozin after stopping:

Treatment Patients
Sitagliptin (Januvia) 3
Metformin (Metformin ER) 2
Pioglitazone (Actos) 2
Canagliflozin-metformin (Invokamet) 1
Glimepiride (Amaryl) 1

Show all 6 treatments patients report switching from

Patients stopped taking Canagliflozin and switched to:

Treatment Patients
Empaglifozin (Jardiance) 5
Dapagliflozin (Farxiga) 1
Ertugliflozin (Steglatro) 1
insulin detemir (Levemir FlexPen) 1
Linagliptin (Tradjenta) 1
Last updated:
There are no evaluations for Canagliflozin.